Table 2.
BCVA (Best Correct Visual Acuity), CMT (Central Macular Thickness), INL (Inner Nuclear Layer), cone density, cone spacing, cone regularity, cone dispersion, angular density (measured at 2° eccentricity from the fovea in the 4 quadrants) (reference for normative values (Sharma, 2023 #2851) and vessel density (measured on OCTA) in the study group.
| Parameter | Total | |
|---|---|---|
| BCVA | 0.18 ± 0.13 | |
| CMT | 291.9 ± 16.6 | |
| INL | 26.2 ± 4.6 | |
| VD SCP | 40.8 ± 5.28 | |
| Density 2° (metric-mm2) | Nasal | 28,425 ± 4619 |
| Superior | 24,963 ± 3687 | |
| Inferior | 25,682 ± 3139 | |
| Temporal | 27,262 ± 5905 | |
| Spacing 2°(metric-micron) | Nasal | 6.62 ± 0.56 |
| Superior | 7.02 ± 0.53 | |
| Inferior | 6.88 ± 0.51 | |
| Temporal | 6.80 ± 0.83 | |
| Regularity 2° (%) | Nasal | 94.70 ± 2.91 |
| Superior | 94.13 ± 3.85 | |
| Inferior | 95.75 ± 4.13 | |
| Temporal | 96.77 ± 2.80 | |
| Dispersion 2° (%) | Nasal | 10.64 ± 2.62 |
| Superior | 12.04 ± 4.28 | |
| Inferior | 10.2 ± 2.55 | |
| Temporal | 9.73 ± 2.27 | |
| Angular density 2° | Nasal | 1953 ± 305 |
| Superior | 1764 ± 134 | |
| Inferior | 1838 ± 158 | |
| Temporal | 1902 ± 306 |
The results of the analyses are expressed as mean ± SD for quantitative variables.